Umemura Kyohei, Fujita Kyoko, Jinno Akiko, Nakamura Ayano, Kamei Motohiro
Department of Ophthalmology, Aichi Medical University, Nagakuteshi, Japan.
Department of Hematology, Aichi Medical University, Nagakuteshi, Japan.
Case Rep Ophthalmol. 2021 Jun 17;12(2):555-561. doi: 10.1159/000516861. eCollection 2021 May-Aug.
We herein report a patient with Philadelphia chromosome-positive lymphoid blast crisis of chronic myeloid leukemia (CML), who presented with bilateral serous retinal detachment (SRD). A 36-year-old Asian male presented with the symptoms of decreased vision and was found to have bilateral SRD involving fovea. There was no inflammation in the anterior chamber or vitreous. Physical examination showed hepatomegaly and splenomegaly. A blood count revealed white blood cell count of 38.2 × 10/L with 51.5% blast cells. Bone marrow aspirate showed total cell count of 145 × 10/μL with 80.6% blast cells and negative neutrophil myeloperoxidase staining. Cytogenetic analysis using fluorescence in situ hybridization confirmed a 9;22 chromosomal translocation, indicating the presence of the Philadelphia chromosome. Flow cytometry analysis demonstrated expression of CD10, CD19, and positive TdT. According to morphology, immunology, cytogenetics, and molecular criteria, the patient was diagnosed as having Philadelphia chromosome-positive lymphoid blast crisis of CML. Based on the ocular findings and hematological abnormalities, the SRD was considered to be ocular involvement secondary to the blast crisis of leukemia. Two months after starting induction therapy, fundus examination and optical coherence tomography showed complete resolution of bilateral SRD and improved vision. Prompt diagnosis of the disease leads to early systemic chemotherapy and may help restore visual function and improve survival.
我们在此报告一例慢性髓性白血病(CML)费城染色体阳性淋巴母细胞危象患者,该患者出现双侧浆液性视网膜脱离(SRD)。一名36岁的亚洲男性因视力下降症状就诊,检查发现双侧SRD累及黄斑。前房和玻璃体无炎症。体格检查显示肝肿大和脾肿大。血常规显示白细胞计数为38.2×10⁹/L,原始细胞占51.5%。骨髓穿刺显示细胞总数为145×10⁶/μL,原始细胞占80.6%,中性粒细胞髓过氧化物酶染色阴性。使用荧光原位杂交进行的细胞遗传学分析证实存在9;22染色体易位,表明存在费城染色体。流式细胞术分析显示CD10、CD19表达及末端脱氧核苷酸转移酶(TdT)阳性。根据形态学、免疫学、细胞遗传学和分子标准,该患者被诊断为CML费城染色体阳性淋巴母细胞危象。基于眼部检查结果和血液学异常,SRD被认为是白血病母细胞危象继发的眼部受累。开始诱导治疗两个月后,眼底检查和光学相干断层扫描显示双侧SRD完全消退,视力改善。对该疾病的及时诊断可促使早期全身化疗,并可能有助于恢复视觉功能和提高生存率。